Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection

Microbes and Infection

Volumn 8, Issue 6, 2006, Pages 1530-1538

  Lefeuvre, Anabelle ^a   Contamin, Hugues ^a   Decelle, Thierry ^b   Fournier, Christophe ^b   Lang, Jean ^b   Deubel, Vincent ^c   Marianneau, Philippe ^a  

^a INSTITUT PASTEUR   (France)

^b SANOFI PASTEUR   (France)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

17D strain; Apoptosis; Hepatic cells; HepG2 cells; Virus attenuation; Yellow fever virus

Indexed keywords

HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 1A; HEAT SHOCK PROTEIN 70 1B; HELIX LOOP HELIX PROTEIN; IMMEDIATE EARLY RESPONSE PROTEIN IEX 1; INTERFERON REGULATORY FACTOR 1; PROTEIN DEC1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; ATTENUATION; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; LIVER CELL; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS ATTENUATION; VIRUS GENE; VIRUS PARTICLE; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE; YELLOW FEVER FLAVIVIRUS;

ANIMALS; ANTIGENS, VIRAL; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION; YELLOW FEVER; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

EID: 33746867143     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.01.013     Document Type: Article

References (47)

1. Lindenbach B.D., and Rice C.M. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 991-1041
2. Digoutte J.P., Cornet M., Deubel V., and Downs W.G. In: Porterfield J.S. (Ed). Exotic Viral Infections (1995), Chapman & Hall, London 67-102
3. Burke D.S., and Monath T.P. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 1043-1125
4. Monath T.P. In: Plotkin S., and Orenstein W.A. (Eds). Vaccines (2004), Saunder, Philadelphia 1095-1176
5. Pugachev K.V., Guirakhoo F., Ocran S.W., Mitchell F., Parsons M., Penal C., Girakhoo S., Pougatcheva S.O., Arroyo J., Trent D.W., and Monath T.P. High fidelity of yellow fever virus RNA polymerase. J. Virol. 78 (2004) 1032-1038
6. Xie H., Cass A.R., and Barrett A.D.T. Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations. Virus Res. 55 (1998) 93-99
7. Barrett A.D.T. Yellow fever vaccines. Biologicals 25 (1997) 17-25
8. Dossantos C.N.D., Post P.R., Carvalho R., Ferreira II, Rice C.M., and Galler R. Complete nucleotide-sequence of yellow-fever virus-vaccine strains 17DD and 17D-213. Virus Res. 35 (1995) 35-41
9. Hahn C.S., Dalrymple J.M., Strauss J.H., and Rice C.M. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2019-2023
10. Chambers T.J., and Nickells M. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J. Virol. 75 (2001) 10912-10922
11. Schlesinger J.J., Chapman S., Nestorowicz A., Rice C.M., Ginocchio T.E., and Chambers T.J. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J. Gen. Virol. 77 Pt 6 (1996) 1277-1285
12. Monath T.P., Brinker K.R., Chandler F.W., Kemp G.E., and Cropp C.B. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am. J. Trop. Med. Hyg. 30 (1981) 431-443
13. McArthur M.A., Suderman M.T., Mutebi J.P., Xiao S.Y., and Barrett A.D.T. Molecular characterization of a hamster viscerotropic strain of yellow fever virus. J. Virol. 77 (2003) 1462-1468
14. Tesh R.B., Guzman H., da Rosa A.P., Vasconcelos P.F., Dias L.B., Bunnell J.E., Zhang H., and Xiao S.Y. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J. Infect. Dis. 183 (2001) 1431-1436
15. Xiao S.Y., Zhang H., Guzman H., and Tesh R.B. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology. J. Infect. Dis. 183 (2001) 1437-1444
16. Tigertt W.D., Berge T.O., Gochenour W.S., and Gleiser C.A. Experimental yellow fever. Trans. N Y Acad. Sci. (1960) 323-333
17. Vieira W.T., Gayotto L.C., de Lima C.P., and de Brito T. Histopathology of the human liver in yellow fever with special emphasis on the diagnostic role of the Councilman body. Histopathology 7 (1983) 195-208
18. Quaresma J.A., Barros V.L., Fernandes E.R., Pagliari C., Takakura C., da Costa Vasconcelos P.F., de Andrade Jr. H.F., and Duarte M.I. Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Trop. 94 (2005) 116-127
19. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209 (1980) 497-499
20. Knowles B.B., Searls D.B., and Aden D.P. In: Chisari F.V. (Ed). Advances in Hepatitis Research (1984), Masson, New York 196-202
21. Harris A.J., Dial S.L., and Casciano D.A. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat. Res. 549 (2004) 79-99
22. Catteau A., Kalinina O., Wagner M.C., Deubel V., Courageot M.P., and Despres P. Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J. Gen. Virol. 84 (2003) 2781-2793
23. Marianneau P., Megret F., Olivier R., Morens D.M., and Deubel V. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J. Gen. Virol. 77 Pt 10 (1996) 2547-2554
24. Thepparit C., Phoolcharoen W., Suksanpaisan L., and Smith D.R. Internalization and propagation of the dengue virus in human hepatoma (HepG2) cells. Intervirology 47 (2004) 78-86
25. Marianneau P., Steffan A.M., Royer C., Drouet M.T., Kirn A., and Deubel V. Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J. Infect. Dis. 178 (1998) 1270-1278
26. Drosten C., Gottig S., Schilling S., Asper M., Panning M., Schmitz H., and Gunther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 40 (2002) 2323-2330
27. Baize S., Kaplon J., Faure C., Pannetier D., Georges-Courbot M.C., and Deubel V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172 (2004) 2861-2869
28. Teodoro J.G., and Branton P.E. Regulation of apoptosis by viral gene products. J. Virol. 71 (1997) 1739-1746
29. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., and Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73 (1999) 510-518
30. Lin Y., Bright A.C., Rothermel T.A., and He B. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J. Virol. 77 (2003) 3371-3383
31. Itoh M., Hotta H., and Homma M. Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J. Virol. 72 (1998) 2927-2934
32. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., and Dietzschold B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J. Virol. 76 (2002) 3374-3381
33. Fadok V.A., Bratton D.L., and Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108 (2001) 957-962
34. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
35. Browne E.P., Wing B., Coleman D., and Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75 (2001) 12319-12330
36. Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., and Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 75 (2001) 750-758
37. Ray N., and Enquist L.W. Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses. J. Virol. 78 (2004) 3489-3501
38. Taddeo B., Esclatine A., and Roizman B. The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 17031-17036
39. Wu M.X. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 8 (2003) 11-18
40. Kirchhoff S., and Hauser H. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis. Oncogene 18 (1999) 3725-3736
41. Kim P.K., Armstrong M., Liu Y., Yan P., Bucher B., Zuckerbraun B.S., Gambotto A., Billiar T.R., and Yim J.H. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene 23 (2004) 1125-1135
42. Li Y., Zhang H., Xie M., Hu M., Ge S., Yang D., Wan Y., and Yan B. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem. J. 367 (2002) 413-422
43. Osawa Y., Nagaki M., Banno Y., Brenner D.A., Nozawa Y., Moriwaki H., and Nakashima S. Expression of the NF-kappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation. J. Immunol. 170 (2003) 4053-4060
44. Arlt A., Kruse M.L., Breitenbroich M., Gehrz A., Koc B., Minkenberg J., Folsch U.R., and Schafer H. The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death. Oncogene 22 (2003) 3343-3351
45. Wu M.X., Ao Z., Prasad K.V., Wu R., and Schlossman S.F. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281 (1998) 998-1001
46. Schilling D., Pittelkow M.R., and Kumar R. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 20 (2001) 7992-7997
47. Park H.S., Cho S.G., Kim C.K., Hwang H.S., Noh K.T., Kim M.S., Huh S.H., Kim M.J., Ryoo K., Kim E.K., Kang W.J., Lee J.S., Seo J.S., Ko Y.G., Kim S., and Choi E.J. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 22 (2002) 7721-7730